Hematology Oncology and Stem Cell Therapy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Is sickle cell disease-related neurotoxicity a systemic endotheliopathy?
Publication date: Available online 13 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Marta Palomo de Udaeta, Maribel Diaz-Ricart, Enric Carreras (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 15, 2020 Category: Cancer & Oncology Source Type: research

Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Dilan A. Patel, Adeseye M. Akinsete, Josu de la Fuente, Adetola A. Kassim (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Status quo of allogeneic stem cell transplantation for patients with sickle cell disease using matched unrelated donors
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): L. Oevermann, Pietro Sodani (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) Congress on Sickle Cell Disease, 16–17 May 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Lisa V.E. Oostenbrink, Cornelia M. Jol-van der Zijde, Anja M. Jansen-Hoogendijk, Emma S. Pool, Astrid G.S. van Halteren, Dirk Jan A.R. Moes, Robbert G.M. Bredius, Alex B. Mohseny, Frans J.W. Smiers, Maarten J.D. van Tol, Marco W. Schilham, Arjan C. Lankester (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Hao Meng Yip, Kwee Yong, Dunnya De-Silva, Neil Rabin (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Alternative Donor: aß/CD3 T-cell depleted Haplo HSCT for Sickle Cell Disease
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Juergen Foell, Katharina Kleinschmidt, Marcus Jakob, Anja Troeger, Selim Corbacioglu (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Using novel magnetic resonance imaging methods to predict stroke risk in individuals with sickle cell anemia
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Lori C. Jordan, Adetola A. Kassim, Karina L. Wilkerson, Chelsea A. Lee, Spencer L. Waddle, Manus J. Donahue (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell Disease in the Eastern Mediterranean
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Ali D. Alahmari, Aljurf M, Alseraihy A, Hamidieh AA, Alkindi S, Rihani R, Satti T, Alsaedi H, Almohareb F, Al-Jefri A, Rasheed W (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Detection of del(16q) using the CBFB-MYH11 translocation dual fusion probe
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Doaa F. Temerik, Walaa T. El-Mahdy, Ahmed Makboul Ahmed (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

What is the place of hematopoietic stem cell transplantation in the management of cerebral vasculopathy in children with sickle cell anemia?
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Françoise Bernaudin (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Proceedings of the Meeting of the Pediatric Disease Working Party (PDWP) of the European Group for Blood and Marrow Transplantation (EBMT) on Sickle Cell Disease 16–17 May 2019, Regensburg, Germany
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Selim Corbacioglu, Eliane Gluckman, Ali Alahmari, Adetola Kassim, Josu de la Fuente (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Should young children with human leukocyte antigen identical sibling donor be offered hematopoietic cell transplantation?
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Lakshmanan Krishnamurti (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Standard management of sickle cell disease complications
Publication date: Available online 12 March 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Miguel R. Abboud (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - March 13, 2020 Category: Cancer & Oncology Source Type: research

Choriocarcinoma Presenting as Skin Lesions and Back Pain
Publication date: Available online 24 December 2019Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Aldanah Mohammed Althwanay, Roqayah Abdullah AlMaradheef, Reem Mohammed Althwanay, Awadia Salman Awadalla, Arwa Abdelhameed Nabhan AbdelhameedAbstractChoriocarcinoma is one of the malignant tumors mostly arising from trophoblastic cells and less likely to arise from germ cells in the testis or ovary or derives from dedifferentiation of other carcinomas. It is characterized by the secretion of Beta Human Chorionic Gonadotrophin (B-HCG). The most common sites of systemic metastatic of choriocarcinoma are lungs, live...
Source: Hematology Oncology and Stem Cell Therapy - December 24, 2019 Category: Cancer & Oncology Source Type: research

Influence of Major Histocompatibility Complex Class I Chain-Related Gene A Polymorphisms on Cytomegalovirus Disease after Allogeneic Hematopoietic Cell Transplantation
ConclusionThese findings suggest that the donor MICA-129 V/V genotype with weak NKG2D receptor binding affinity is associated with an increased risk of CMV infection and disease after alloHCT. (Source: Hematology Oncology and Stem Cell Therapy)
Source: Hematology Oncology and Stem Cell Therapy - December 24, 2019 Category: Cancer & Oncology Source Type: research